Hu, Hao https://orcid.org/0000-0003-3622-9897
Lin, Peter Bor-Chian https://orcid.org/0000-0002-8954-9045
Zeng, Carisa https://orcid.org/0000-0002-7108-3873
Li, Yongyi https://orcid.org/0009-0009-1001-3095
Bosch, Megan E.
Emmerson, Joshua T. https://orcid.org/0000-0001-6007-4341
Sharma, Prabal
Ohara, Ray A. https://orcid.org/0000-0001-7897-3169
Dong, Wendy https://orcid.org/0000-0002-5663-7372
Wu, Tong https://orcid.org/0000-0001-9121-2495
Du, Siling https://orcid.org/0000-0003-1540-3585
Gao, Wenqing
Jiang, Hong
Yuan, Liya
Bao, Xin
Li, Shasha
Vomund, Anthony N.
Erdmann-Gilmore, Petra
Gu, Yichen
Hu, Miwei
Nulman, Jonathan https://orcid.org/0000-0002-8887-4532
Miller, Timothy M.
Yokoyama, Wayne M. https://orcid.org/0000-0002-0566-7264
Lichti, Cheryl F. https://orcid.org/0000-0003-4099-4954
Milbrandt, Jeffrey https://orcid.org/0000-0002-5477-7689
Perrin, Richard J. https://orcid.org/0000-0002-3443-7716
Kipnis, Jonathan https://orcid.org/0000-0002-3714-517X
Artyomov, Maxim N.
Murphy, Kenneth M. https://orcid.org/0000-0002-3505-9630
Ulrich, Jason D. https://orcid.org/0000-0002-4743-926X
Holtzman, David M. https://orcid.org/0000-0002-3400-0856
Article History
Received: 27 November 2025
Accepted: 23 July 2026
First Online: 3 September 2026
Ethics
Competing interests: D.M.H. cofounded, has equity and is on the scientific advisory board of C2N Diagnostics. D.M.H. is on the scientific advisory board of Genentech, Denali and Switch, and consults for Pfizer, Annexon, Novartis and Roche. J.K. is a cofounder of Pranas Neuro and Rho Bio. T.M.M. is a consultant for Ionis Pharmaceuticals, Biogen and Arbor Biosciences. T.M.M. has licensing agreements with Ionis Pharmaceuticals and C2N Diagnostics. All other authors declare no competing interests.